Generate a tailored SOP for Dr. Rehana Hewavisenti. Improve your application with a focused, well-structured draft.
Rehana Hewavisenti is an early career researcher focused on human translational immunology with special interests in understanding immune responses to virally-induced cancer and sepsis pancreatitis. She completed her PhD at the Centenary Institute of Cancer Medicine and Cell Biology and the University of Sydney, where she focused on the phenotypic and functional characteristics of tissue-resident T cells in human disease. Dr. Hewavisenti aims to further her work in virology, infectious disease, and cancer immunology, specifically in understanding and harnessing the immune system to prevent persistent disease and cancer development. Her research experience has equipped her with a strong multidisciplinary profile in translational immunology, T cell biology, and molecular biology, with a specific emphasis on HPV-driven malignancies. Her work within the Immunovirology Pathogenesis Program at the Kirby Institute revolves around translational immunology and T cell biology in HPV and virally-driven cancers affecting immunocompromised individuals.
Kirby Institute • Sydney
Conducting research in translational immunology with focus on T cell biology and virally-induced cancers.
Includes Business Intelligence, Enterprise Systems, and Cybersecurity Management streams.